Sage Journals: Discover world-class research

Free access

Review article

First published 2019-1

Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases

JG Sanchez-Hernandez, N Rebollo, F Munoz [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open access

Research article

First published 2022-1

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor

Shin Yee Chey, Allan G. Kermode

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2021

Tumour necrosis factor inhibitor tapering in patients with ankylosing spondylitis at low disease activity: factors associated with flare

Oh Chan Kwon, Jung Hwan Park, Min-Chan Park

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2021

Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues

Laurent Peyrin-Biroulet, William J. Sandborn, Remo Panaccione [...]

Therapeutic Advances in Gastroenterology

Open access

Case report

First published 2021

A case report about adalimumab-induced radiologically isolated syndrome: A significant side effect of tumour necrosis factor inhibitors

Joshua Onasanya, Renée A Beach

Sage Open Medical Case Reports

Free access

Research article

First published 1998-4

Isolation and Characterization of the Fungal Metabolite 3-O-Methylviridicatin as an Inhibitor of Tumour Necrosis Factor α-Induced Human Immunodeficiency Virus Replication

A Heguy, P Cai, P Meyn [...]

Antiviral Chemistry and Chemotherapy

Open access

Research article

First published 2021

Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice

Yi-Teng Hung, Yu-Jr Lin, Hsien-Yi Chiu [...]

Sage Open Chronic Disease

Open access

Research article

First published 2021

Factors affecting drug survival of an alternative TNF inhibitor and secukinumab in patients with ankylosing spondylitis switching from the first TNF inhibitor

Oh Chan Kwon, Jung Hwan Park, Min-Chan Park

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2021

Rapid improvement in spinal pain in patients with axial spondyloarthritis treated with secukinumab: primary results from a randomized controlled phase-IIIb trial

Denis Poddubnyy, Effie Pournara, Agnieszka Zielińska [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2025-11

Therapeutic Drug Monitoring in Hidradenitis Suppurativa Patients With Suboptimal Treatment Response to Adalimumab

Hannah Stirton, Raed Alhusayen

Journal of Cutaneous Medicine and Surgery

Search results